secwatch.observer — SEC 8-K summary
======================================

Issuer:     Niagen Bioscience, Inc. (NAGE)
CIK:        0001386570
Form:       8-K
Filed at:   2026-02-26T23:59:59+00:00
Accession:  0001386570-26-000003
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.60
Item codes: 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Niagen Bioscience sells ChromaDex Reference Standards business to LGC in all-cash deal
--------------------------------------------------------------------------------

- All-cash sale closed Feb 24, 2026; buyer is VHG Labs, part of LGC Group.
- Divestiture exits non-core activities; focuses on NAD+ science, IP, commercial growth.
- Transition services agreement for up to 6 months; service fee recognized as performed.
- No purchase price or financial terms disclosed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1386570/000138657026000003/0001386570-26-000003-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1386570/000138657026000003/cdxc-20260224.htm
  HTML page:      https://secwatch.observer/filing/0001386570-26-000003

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer